Nasdaq · Healthcare
ANGIODYNAMICS INC (ANGO)
As-reported financials and recent SEC filings for ANGIODYNAMICS INC, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$292.5M
Net income
$-34.0M
Net margin
-11.6%
Diluted EPS
$-0.83
ROE
-18.6%
P/E (TTM)
—
Market cap
$553.7M
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $292.5M | $303.9M | $338.8M | $316.2M | $291.0M |
| Gross profit | $157.7M | $154.7M | $174.2M | $165.7M | $156.8M |
| Operating income | $-40.0M | $-192.4M | $-51.2M | $-28.5M | $-35.3M |
| Net income | $-34.0M | $-184.3M | $-52.4M | $-26.5M | $-31.5M |
| Diluted EPS | $-0.83 | $-4.59 | $-1.33 | $-0.68 | $-0.82 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
SCHEDULE 13G/A2026-05-15
View on EDGAR →8-K2026-04-23
View on EDGAR →10-Q2026-04-02
View on EDGAR →8-K2026-04-02
View on EDGAR →SCHEDULE 13G/A2026-03-26
View on EDGAR →SCHEDULE 13G/A2026-02-13
View on EDGAR →SCHEDULE 13G2026-02-10
View on EDGAR →SCHEDULE 13G2026-02-09
View on EDGAR →Go deeper on ANGO
Search ANGIODYNAMICS INC’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.